BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND TCL1A, P56279, 8115, ENSG00000100721, TCL1
38 results:

  • 1. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations.
    Shumilov E; Mazzeo P; Ghandili S; Künstner A; Weidemann S; Banz Y; Ströbel P; Pollak M; Kolloch L; Beltraminelli H; Kerkhoff A; Mikesch JH; Schliemann C; Haase D; Wulf G; Legros M; Lenz G; Feldmeyer L; Pabst T; Witte H; Gebauer N; Bacher U
    Ann Hematol; 2024 May; 103(5):1587-1599. PubMed ID: 38194088
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Frontline Hyper-CVAD Plus Venetoclax for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm.
    He J; Garcia MB; Connors JS; Nuñez CA; Quesada AE; Gibson A; Roth M; Cuglievan B; Pemmaraju N; McCall D
    J Pediatr Hematol Oncol; 2023 Nov; 45(8):e1001-e1004. PubMed ID: 37661300
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Jain A; Sweet K
    J Natl Compr Canc Netw; 2023 May; 21(5):515-521. PubMed ID: 37156483
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. IRF8 may be a useful marker for blastic plasmacytoid dendritic cell neoplasm, especially with weak CD123 expression.
    Tang H; Panse G; Braddock D; Perincheri S; Xu ML; McNiff JM
    J Cutan Pathol; 2023 Jul; 50(7):595-600. PubMed ID: 37082914
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Blastic plasmacytoid dendritic cell neoplasm: A clinico-pathological retrospective analysis of thirteen cases].
    Nong L; Wang W; Liang L; Li D; Li X; Li T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):308-314. PubMed ID: 37042142
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Delineation of clinical course, outcomes, and prognostic factors in patients with T-cell prolymphocytic leukemia.
    Rose A; Zhang L; Jain AG; Poovathukaran Babu A; Sokol L; Saeed H; Mo Q; Fan W; Zhang X
    Am J Hematol; 2023 Jun; 98(6):913-921. PubMed ID: 36964941
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Diagnosis, treatment, and genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A review.
    Wang Y; Xiao L; Yin L; Zhou L; Deng Y; Deng H
    Medicine (Baltimore); 2023 Feb; 102(7):e32904. PubMed ID: 36800625
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Immunogenomic correlates of immune-related adverse events for anti-programmed cell death 1 therapy.
    Zhang L; Shi Y; Han X
    Front Immunol; 2022; 13():1032221. PubMed ID: 36505471
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial): Reassessment of 4-year efficacy outcomes in patients with stage III melanoma per AJCC-8 staging criteria.
    Larkin J; Weber J; Del Vecchio M; Gogas H; Arance AM; Dalle S; Cowey CL; Schenker M; Grob JJ; Chiarion-Sileni V; Márquez-Rodas I; Butler MO; Di Giacomo AM; Middleton MR; De la Cruz-Merino L; Arenberger P; Atkinson V; Hill A; Fecher LA; Millward M; Khushalani NI; Queirolo P; Long GV; Lobo M; Askelson M; Ascierto PA; Mandalá M
    Eur J Cancer; 2022 Sep; 173():285-296. PubMed ID: 35964471
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cytomorphological and immunophenotypic characteristics of blastic plasmacytoid dendritic cell neoplasm involving central nervous system: a case report and review of literature.
    Prasad T; Pushpam D; Chopra A
    Cytopathology; 2022 Jul; 33(4):522-529. PubMed ID: 35119790
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy.
    Wilson NR; Konopleva M; Khoury JD; Pemmaraju N
    Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):734-740. PubMed ID: 34226167
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Spontaneous Regression of Blastic Plasmacytoid Dendritic Cell Neoplasm Following Sepsis by Serratia marcescens: A Case Report and Literature Review.
    Suzuki A; Abe S; Koyama K; Suzuki S; Nagao M; Kobayashi M; Nomura J; Tsutsumi T; Takeda T; Oka Y; Shirota Y; Takasawa N; Kodera T; Okitsu Y; Takahashi S; Ichinohasama R; Kameoka J
    Intern Med; 2021; 60(6):927-933. PubMed ID: 33716255
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Dendritic Cell Leukemia: a Review.
    Tsagarakis NJ; Paterakis G
    Curr Oncol Rep; 2020 May; 22(6):55. PubMed ID: 32415624
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm.
    Zhang X; Sun J; Yang M; Wang L; Jin J
    Crit Rev Oncol Hematol; 2020 May; 149():102928. PubMed ID: 32234682
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. An analysis of blastic plasmacytoid dendritic cell neoplasm with translocations involving the MYC locus identifies t(6;8)(p21;q24) as a recurrent cytogenetic abnormality.
    Sumarriva Lezama L; Chisholm KM; Carneal E; Nagy A; Cascio MJ; Yan J; Chang CC; Cherry A; George TI; Ohgami RS
    Histopathology; 2018 Nov; 73(5):767-776. PubMed ID: 29884995
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Adult T-cell leukemia/lymphoma can be indistinguishable from other more common T-cell lymphomas. The University of Miami experience with a large cohort of cases.
    Khanlari M; Ramos JC; Sanchez SP; Cho-Vega JH; Amador A; Campuzano-Zuluaga G; Vega F; Chapman JR
    Mod Pathol; 2018 Jul; 31(7):1046-1063. PubMed ID: 29449683
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinicopathological analysis of 46 cases with CD4
    Suzuki Y; Kato S; Kohno K; Satou A; Eladl AE; Asano N; Kono M; Kato Y; Taniwaki M; Akiyama M; Nakamura S
    Histopathology; 2017 Dec; 71(6):972-984. PubMed ID: 28795410
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. T-cell prolymphocytic leukemia frequently shows cutaneous involvement and is associated with gains of MYC, loss of ATM, and tcl1a rearrangement.
    Hsi AC; Robirds DH; Luo J; Kreisel FH; Frater JL; Nguyen TT
    Am J Surg Pathol; 2014 Nov; 38(11):1468-83. PubMed ID: 25310835
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Blastic plasmacytoid dendritic cell neoplasm revealed by ecchymotic lesions on the face].
    Ahogo KC; Wantz M; Cliquennois M; Gosset P; Lebas D; Modiano P
    Ann Dermatol Venereol; 2014 Jan; 141(1):43-7. PubMed ID: 24461094
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients.
    Julia F; Dalle S; Duru G; Balme B; Vergier B; Ortonne N; Vignon-Pennamen MD; Costes-Martineau V; Lamant L; Dalac S; Delattre C; Déchelotte P; Courville P; Carlotti A; De Muret A; Fraitag S; Levy A; Mitchell A; Petrella T
    Am J Surg Pathol; 2014 May; 38(5):673-80. PubMed ID: 24441662
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.